Detection of (1→3)-β-D-glucan as an adjunct to diagnosis in a mixed population with uncommon proven invasive fungal diseases or with an unusual clinical presentation

Clinical and Vaccine Immunology

Volumn 16, Issue 3, 2009, Pages 423-426

  Cuétara, María Soledad ^a   Alhambra, Almudena ^b   Moragues, María Dolores ^c   González Elorza, Ernesto ^c   Pontón, José ^c   Del Palacio, Amalia ^b  

^a HOSPITAL SEVERO OCHOA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; HYALIN; ITRACONAZOLE; TERBINAFINE; VORICONAZOLE; BETA GLUCAN; BETA-1,3-D-GLUCAN;

ADULT; AGED; ALTERNARIA INFECTORIA; ARTICLE; ASPERGILLUS; BLASTOSCHIZOMYCES CAPITATUS; CHILD; CLADOSPORIUM; CLADOSPORIUM MACROCARPUM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; FUSARIUM SOLANI; HUMAN; MALE; MOULD; MYCOSIS; NONHUMAN; OBSERVATIONAL STUDY; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCEDOSPORIUM APIOSPERMUM; ALTERNARIA; BLOOD; DIPODASCUS; EVALUATION; FUSARIUM; ISOLATION AND PURIFICATION; MIDDLE AGED; SCEDOSPORIUM;

AGED; ALTERNARIA; ASPERGILLUS; BETA-GLUCANS; CHILD, PRESCHOOL; CLADOSPORIUM; DIPODASCUS; FEMALE; FUSARIUM; HUMANS; MALE; MIDDLE AGED; MYCOSES; PROSPECTIVE STUDIES; SCEDOSPORIUM;

EID: 61949263794     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00009-09     Document Type: Article

References (14)

1. Chamilos, G., M. Luna, G. E. Lexis, G. P. Bodey, R. Chemaly, J. J. Tarrand, A. Safdar, I. I. Raad, and D. P. Kontoyiannis. 2006. Invasive fungal infections in patients with hematologic malignancies in a tertiary care center: an autopsy over a 15 year period (1989-2003). Haematologica 91:986-989.
2. Cuétara, M. S., A. Alhambra, J. M. Moreno, C. Postigo, M. D. Moragues, J. Pontón, and A. del Palacio. 2006. Invasive aspergillosis due to subungual onychomycosis during treatment for non-Hodgkin lymphoma. Br. J. Dermatol. 154:1200-1201.
3. de Hoog, G. S., J. Guarro, J. Gené, and M. J. Figueras. 2000. Atlas of clinical fungi. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands.
4. De Pauw, B., T. J. Walsh, J. P. Donnelly, D. A. Stevens, J. E. Edwards, T. Calandra, P. G. Pappas, J. Maertens, O. Lortholary, C. A. Kauffman, D. W. Denning, T. F. Patterson, J. Maschmeyer, J. Bille, W. E. Dismukes, R. Herbrecht, W. W. Hope, C. C. Kibbler, B. J. Kullberg, K. A. Marr, P. Muñoz, F. C. Odds, J. R. Perfect, A. Restrepo, M. Ruhnke, B. H. Segal, J. D. Sobel, T. C. Sorrell, C. Viscoli, J. R. Wingard, T. Zaoutis, and J. E. Bennett. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin. Infect. Dis. 46:1813-1821.
5. Gilgado, F., J. Cano, J. Gené, D. A. Sutton, and J. Guarro. 2008. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J. Clin. Microbiol. 46:766-771.
6. Michaels, A. J., and P. V. Draganov. 2007. Endoscopic ultrasonography guided celiac plexus neurolysis and celiac plexus block in the management of pain due to pancreatic cancer and chronic pancreatitis. World J. Gastroenterol. 13:3575-3580.
7. Odabasi, Z., G. Mattiuzzi, E. Estey, H. Kantarjian, F. Saeki, R. J. Ridge, P. A. Ketchum, M. A. Finkelman, J. H. Rex, and L. Ostrosky-Zeichner. 2004. β-D-Glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukaemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205.
8. Odabasi, Z., V. L. Paetznick, J. R. Rodriguez, E. Chen, M. R. McGinnis, and L. Ostrosky-Zeichner. 2006. Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med. Mycol. 44:267-272.
9. Ostrosky-Zeichner, L., B. D. Alexander, D. H. Kett, J. Vazquez, P. G. Pappas, F. Saeki, P. A. Ketchum, J. Wingard, R. Schiff, H. Tamura, M. A. Finkelman, and J. H. Rex. 2005. Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41:654-659.
10. Pazos, C., J. Pontón, and A. Del Palacio. 2005. Contribution of (1→3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J. Clin. Microbiol. 43:299-305.
11. Persat, F., S. Ranque, F. Derouin, A. Michel-Nguyen, S. Picot, and A. Sulahian. 2008. Contribution of the (1→3)-β-D-glucan assay for the diagnosis of invasive fungal infections. J. Clin. Microbiol. 46:1009-1013.
12. Revankar, S. G., D. A. Sutton, and M. G. Rinaldi. 2004. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin. Infect. Dis. 38:206-216.
13. Sandven, P., H. Quist, E. Skoulund, and K. E. Giercksky. 2002. Significance of Candida recovered from intraoperative specimens in patients with intraabdominal perforations. Crit. Care Med. 30:541-547.
14. Walsh, T. J., A. Groll, J. Hiemenz, R. Fleming, E. Roilides, and E. Anaissie. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10(Suppl. 1):48-66.